Literature DB >> 2952806

Role of receptor-binding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells.

L C Eisenlohr, W Gerhard, C J Hackett.   

Abstract

The concentration of antigen required to stimulate influenza virus-specific helper T cells was observed to be dependent upon the antigenic form bearing the relevant determinant: intact, nonreplicative virus was needed only in picomolar amounts, while denatured proteins, protein fragments, or synthetic peptides were required in micromolar concentrations for a threshold level of stimulation. Antigenic efficiency of intact virus was found to result from the attachment of virus to sialic acid residues on the surface of the antigen-presenting cell since spikeless viral particles lacking the hemagglutinin molecule were much less efficient antigens for helper T cells and continuous presence of hemagglutination-inhibiting antihemagglutinin antibodies reduced efficiency of stimulation by intact virus approximately 100-fold for both hemagglutinin and internal virion proteins. Influenza virus associated rapidly with antigen-presenting cells; less than 10 min at 20 degrees C was sufficient to introduce virus for a maximal level of T-cell stimulation. This rapid attachment was blocked by antibodies to the hemagglutinin or by pretreatment of the antigen-presenting cells with neuraminidase to remove the cellular virus receptor. Following viral adsorption by antigen-presenting cells, a lag period of 30 min at 37 degrees C was required for the expression of helper T-cell determinants. One early event identified was the movement of the virus to a neuraminidase-insensitive compartment, which can occur at 10 degrees C, but which was not equivalent to expression of helper T-cell determinants. Preincubation of cells with virus at 10 degrees C for 4 h reduced the lag period of helper T-cell determinant expression to 15 min when these cells were shifted to 37 degrees C, suggesting that transition of the virus to a neuraminidase-resistant state is a required step in presentation of T-cell antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952806      PMCID: PMC254112     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Counts of influenza virus particles.

Authors:  H B DONALD; A ISAACS
Journal:  J Gen Microbiol       Date:  1954-06

2.  T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.

Authors:  A M Solinger; M E Ultee; E Margoliash; R H Schwartz
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

3.  Low temperature selectively inhibits fusion between pinocytic vesicles and lysosomes during heterophagy of 125I-asialofetuin by the perfused rat liver.

Authors:  W A Dunn; A L Hubbard; N N Aronson
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

4.  Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells.

Authors:  R M Maizels; J A Clarke; M A Harvey; A Miller; E E Sercarz
Journal:  Eur J Immunol       Date:  1980-07       Impact factor: 5.532

5.  Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs.

Authors:  J W Thomas; W Danho; E Bullesbach; J Föhles; A S Rosenthal
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

Review 6.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

7.  Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses.

Authors:  G M Butchko; R B Armstrong; F A Ennis
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  Expression of influenza A virus internal antigens on the surface of infected P815 cells.

Authors:  J W Yewdell; E Frank; W Gerhard
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

9.  A T helper cell for anti-viral cytotoxic T-cell responses.

Authors:  R B Ashman; A Müllbacher
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

10.  Lymphocyte specificity to protein antigens. II. Fine specificity of T-cell activation with cytochrome c and derived peptides as antigenic probes.

Authors:  G Corradin; J M Chiller
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

2.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.

Authors:  W Gerhard; A M Haberman; P A Scherle; A H Taylor; G Palladino; A J Caton
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus.

Authors:  C J Hackett; D Horowitz; M Wysocka; L C Eisenlohr
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 4.  Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus.

Authors:  C J Hackett; L C Eisenlohr
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Authors:  R A Ffrench; X L Tang; E M Anders; D C Jackson; D O White; H Drummer; J D Wade; G W Tregear; L E Brown
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.

Authors:  K H Mills
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

7.  Immunity to influenza A H9N2 viruses induced by infection and vaccination.

Authors:  X Lu; M Renshaw; T M Tumpey; G D Kelly; J Hu-Primmer; J M Katz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus.

Authors:  C A Lamb; J W Yewdell; J R Bennink; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

9.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Immunogenicity of free synthetic peptides corresponding to T helper epitopes of the influenza HA 1 subunit. Induction of virus cross reacting CD4+ T lymphocytes in mice.

Authors:  C Schneider; M H Van Regenmortel
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.